Target intelligence / Profile preview

Caveolin-2 (CAV2)

Target
CAV2
Molecular classification
Caveolin family member, Caveolae structural protein
01

Overview

Caveolin-2 is a small integral membrane protein (~20 kDa) that forms a major component of caveolae, specialized invaginations of the plasma membrane enriched in cholesterol and sphingolipids. Caveolin-2 tightly interacts with caveolin-1 to form hetero-oligomeric complexes necessary for proper caveolae assembly and cell surface localization. It regulates multiple cell functions, including signaling, lipid metabolism, cell growth, and apoptosis. Caveolin-2 is typically phosphorylated at specific serine residues, which modulate its ability to regulate caveolae formation and function. While caveolin-2’s role is less defined than caveolin-1, it is increasingly recognized as an important contributor to disease biology, especially in cancer and cardiovascular contexts. Its function is tissue- and cell-type specific, reflecting context-dependent interactions and signaling regulation. Caveolin-2 interacts most directly with caveolin-1, is phosphorylated by Src and casein kinase II, and has been implicated more recently in direct signaling roles distinct from caveolin-1, particularly in the context of disease. There are currently no direct therapeutics for caveolin-2, but its significance in pathology and its biomarker potential make it an emerging focus in translational medicine.

Other names
Caveolin-2CAV2caveolae protein, 20-kDCAVCAV2 protein
02

Mechanism of action

Not directly applicable; caveolin-2 modulates caveolae-associated signaling and function, often by scaffolding and regulating the availability/activity of signaling molecules, especially via phosphorylation states.

03

Biological functions

Signal transductionLipid metabolismCell growth controlApoptosisCaveolae biogenesisCellular transport
04

Disease associations

Cancer (possible tumor suppressor role, implicated in cancer biology)Cardiovascular diseaseInflammationInfection (roles in cell response to infection are reported)Other (potential involvement in neurodegenerative disease and metabolic disorders per emerging research)
05

Safety considerations

Targeting caveolin-2 may pose challenges due to its ubiquitous expression, tissue-specific signaling roles, and the importance of phosphorylation for its function, meaning off-target effects could impair essential cellular processesRedundancy with caveolin-1 must be considered
06

Biomarkers

Caveolin-2 itself can serve as a biomarker in cancer and inflammation researchIts expression/phosphorylation status is sometimes used in tissue profiling

Beyond the preview

Go deeper on Caveolin-2 (CAV2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caveolin-2 (CAV2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call